Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 0: clinchem.2006.067082v2, 2006; 10.1373/clinchem.2006.067082
This Article
Right arrow Full Text (PDF)
Right arrow 067082.Supplemental Data Table 1
Right arrow All Versions of this Article:
clinchem.2006.067082v1
clinchem.2006.067082v2
52/7/1420    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abdollahi, M. R.
Right arrow Articles by Monsarratt Day, I. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abdollahi, M. R.
Right arrow Articles by Monsarratt Day, I. N.

Received on ,
Accepted on ,

Technical Briefs

Integrated Single-Label Liquid-Phase Assay of APOE Codons 112 and 158 and Lipoprotein: A Study in British Women

Mohammad Reza Abdollahi 1*, Philip Alexander Isles Guthrie 1, George Davey Smith 2, Debbie A. Lawlor 2, Shah Ebrahim 3, Ian Nicholas Monsarratt Day 4

1 Bristol Genetic Epidemiology Laboratory, University of Bristol, Bristol, United Kingdom
2 Department of Social Medicine, University of Bristol, Bristol, United Kingdom
3 Department of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom
4 Bristol Genetic Epidemiology Laboratory, University of Bristol, Bristol, United Kingdom, and Human Genetics Division, MP 808, Southampton General Hospital, Southampton, United Kingdom

Background: Apolipoprotein E (APOE) is an important element of lipid metabolism and, hence, cardiovascular disorders. APOE has 3 main allelic variants: {varepsilon}3, {varepsilon}4, and {varepsilon}2. Of these, {varepsilon}3 is the most common, followed by {varepsilon}4 and {varepsilon}2. The associations of these isoforms with cardiovascular disorders and Alzheimer disease have been widely studied in different populations. Most of the genotyping in these studies has been performed with gel-based methods, which have important limitations, particularly for large epidemiologic studies. We therefore developed an integrated "one-tube" liquid-phase assay.

Methods: To measure APOE isoforms, we developed an integrated single-label liquid-phase fluorescence assay containing 2 PCR primers, 2 probes, and 2 quencher oligonucleotides. We used a 384-well LightTyper, but the assay would be generically applicable for use with any fluorescence detector with thermal ramp control. We validated this method and applied it in the British Women\'s Heart and Health Study.

Results: There were 4 melting peaks, at 40, 56, 61, and 69 °C, which generated 6 distinctive patterns representing genotypic combinations of {varepsilon}3, {varepsilon}4, and {varepsilon}2. The magnitude and direction of the associations found with total cholesterol, HDL-cholesterol, triglycerides, and estimated LDL-cholesterol were consistent with previous reports.

Conclusion: The one-tube LightTyper assay presented here enables accurate, convenient, and economical genotyping of APOE and can be used for large epidemiologic studies.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Association for Clinical Chemistry.